Evolving information technology, government regulations, and new healthcare legislation present unique challenges for everyone involved in the healthcare industry. Scientia maintains an ongoing dialog with knowledge and opinion leaders to stay on top of emerging trends that may impact the industry and our clients' businesses. This strategic knowledge adds value to our clients from day one of our engagements.
Experience where it brings the most value
Areas of Expertise
Scientia works exclusively with clients in the life science and healthcare industry. Some of our clients are established leaders in their field; others are expanding operations into the life sciences and/or healthcare; and others are starting up operations based on a new concept or technology. We offer these clients expert consultation services in the following areas.
Healthcare Trends
In vitro Diagnostics
Global changes affecting in vitro diagnostic (IVD) like genomics, personalized medicine and health IT are causing IVD markets to enter an exciting new phase. Emergence of high value diagnostics is increasing the importance of IVD to healthcare and accelerating the market growth potential, despite the current economy. At Scientia, we help our clients understand new developments and trends in IVD and identify growing and emerging opportunities for strategic action.
Life Science Tools & Technology
Great healthcare starts with great science. Universities and research labs are continuously pushing the edge in core areas such as genomics, proteomics, cellular/functional biology and providing innovation with the design of new medical devices and therapies. The life sciences tools & technologies sector, however, is a highly complex market and a particularly challenging one to compete in due to its shifting structure and changing constituent players. At Scientia, we keep up with the latest trends and breakthroughs, and help you position your company for sustainable and profitable growth.
Medical Devices
Innovative medical devices are enabling critical advances in healthcare delivery. These novel products, combining therapeutic benefits with breakthrough delivery techniques, are disrupting existing markets and creating new opportunities. Scientia helps clients leverage these opportunities to drive future growth and achieve competitive leadership.
Nutrition & Wellness
Nutrition and Wellness is an especially exciting growth market. The combination of continuing scientific advances and an increasingly well-informed population is driving new opportunities. But, realizing those opportunities requires that companies synthesize both good science and good consumer marketing — nutritional products won't work if consumers don't eat them. Scientia has studied the successes and the failures of participants in the field and helps its clients profitably expand their presence in this rapidly developing marketplace.
Therapeutics
Although significant challenges exist in therapeutics markets, there are significant opportunities for companies that can adapt to the ever-changing healthcare landscape. Some of the greatest opportunities reside in biologic therapies, personalized medicine, and emerging economies. At Scientia, we work with large pharmaceutical, biotech, specialty pharmaceutical, contract manufacturers and drug delivery companies to successfully navigate the impact of disruptive change on their business, and help them outperform their peers and position themselves for future growth.
Examples of Scientia articles and perspectives on trends in these areas are available in the Industry Briefings and Industry Reviews sections of this website.
Scientia Leaders »
Harry Glorikian »
Founder and Managing Partner
Arshad Ahmed »
Founding Partner
Patrick Terry »
Principal
Industry Reviews »
Upcoming Conferences
February 22, 2012
Molecular Med TRI-CON 2012: Harry Glorikian on Plenary Keynote Panel: Emerging Technologies & Industry Perspectives
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
